Company Bioaccent Srl with Fiscal Code 35629683
recorded a turnover of 2024 of
319.490,
with a net profit of
67.921
and having an average number of employees of
2.
The company operates in the field of Comerţ cu ridicata specializat al altor alimente having the NACE code 4638.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Bioaccent Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
14.521
52.892
107.107
93.379
152.088
257.289
204.535
293.515
319.490
Total Income - EUR
-
14.688
53.722
107.493
94.104
154.046
257.525
206.615
364.806
325.293
Total Expenses - EUR
-
16.702
44.083
83.104
72.931
106.950
179.656
177.626
292.539
249.529
Gross Profit/Loss - EUR
-
-2.014
9.639
24.389
21.172
47.096
77.869
28.989
72.268
75.764
Net Profit/Loss - EUR
-
-2.450
8.053
22.814
20.232
45.691
75.603
27.243
69.685
67.921
Employees
-
1
1
1
1
1
1
1
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 9.5%, from 293.515 euro in the year 2023, to 319.490 euro in 2024.
The Net Profit decreased by -1.374 euro, from 69.685 euro in 2023, to 67.921 in the last year.
Check the financial reports for the company - Bioaccent Srl
Financial Rating - BIOACCENT SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Bioaccent Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Bioaccent Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Bioaccent Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
184.856 euro in 2024 which includes Inventories of
51.373 euro, Receivables of
114.544 euro and cash availability of
18.939 euro.
The company's Equity was valued at
184.611 euro, while total Liabilities amounted to
10.507 euro.
Equity decreased by -278 euro, from 185.928 euro in 2023, to 184.611 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Bioaccent Srl